Skip to main content

High-Throughput Screening of the Cyclic AMP-Dependent Protein Kinase (PKA) Using the Caliper Microfluidic Platform

Part of the Methods in Molecular Biology book series (MIMB,volume 565)

Abstract

Inhibitors of kinase activities can be mechanistically diverse, genomically selective, and pathway sensitive. This potential has made these biological targets the focus of a number of drug discovery and development programs in the pharmaceutical industry. To this end, the high-throughput screening of kinase targets against diverse chemical libraries or focused compound collections is at the forefront of the drug discovery process. Thus, the platform technology used to screen such libraries must be flexible and produce reliable and comparable data. The Caliper HTS microfluidic platform provides a direct determination of a peptidic substrate and phosphorylated product through the electrophoretic separation of the two species. The resulting data are reliable and comparable among screens and cover a broad range of biological targets, provided there is a definable peptide substrate that permits separation. Here we present a method for the high-throughput screening of the cyclic AMP-dependent protein kinase (PKA) as an example of the simplicity of this microfluidic platform.

Key words

  • Microfluidics
  • Kinase
  • PKA
  • High-throughput screening
  • HTS
  • Caliper

This is a preview of subscription content, access via your institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-60327-258-2_11
  • Chapter length: 13 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   129.00
Price excludes VAT (USA)
  • ISBN: 978-1-60327-258-2
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   169.99
Price excludes VAT (USA)
Hardcover Book
USD   169.99
Price excludes VAT (USA)
Fig. 11.1.
Fig. 11.2.
Fig. 11.3.
Fig. 11.4.
Fig. 11.5.

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. O'Neill, L.A. (2006) Targeting signal transduction as a strategy to treat inflammatory diseases. Nat. Rev. Drug Discov. 5(7), 549–563.

    CrossRef  Google Scholar 

  2. Hennessy, B.T., Smith, D.L., Ram, P.T., Lu, Y., Mills, G.B. (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4(12), 988–1004.

    CrossRef  CAS  Google Scholar 

  3. Vlahos, C.J., McDowell, S.A., Clerk, A. (2003) Kinases as therapeutic targets for heart failure. Nat. Rev. Drug Discov. 2(2), 99–113.

    CrossRef  CAS  Google Scholar 

  4. Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J., Lydon, N.B. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Med. 2(5), 561–566.

    CrossRef  CAS  Google Scholar 

  5. Warner, G., Illy, C., Pedro, L., Roby, P., Bosse, R. (2004) AlphaScreen kinase HTS platforms. Curr. Med. Chem. 11(6), 721–730.

    CrossRef  CAS  Google Scholar 

  6. Sportsman, J.R., Gaudet, E.A., Boge, A. (2004) Immobilized metal ion affinity-based fluorescence polarization (IMAP): advances in kinase screening. Assay Drug Dev. Technol. 2(2), 205–214.

    CrossRef  CAS  Google Scholar 

  7. Koresawa, M., Okabe, T. (2004) High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope, homogeneous assay for protein kinase. Assay Drug Dev. Technol. 2(2), 153–160.

    CrossRef  CAS  Google Scholar 

  8. Dunne, J., Reardon, H., Trinh, V., Li, E., Farinas, J. (2004) Comparison of on-chip and off-chip microfluidic kinase assay formats. Assay Drug Dev. Technol. 2(2), 121–129.

    CrossRef  CAS  Google Scholar 

  9. Cheng, H.C., Kemp, B.E., Pearson, R.B., Smith, A.J., Misconi, L., Van Patten, S.M., Walsh, D.A. (1986) A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J. Biol. Chem. 261(3), 989–992.

    CAS  Google Scholar 

  10. Janzen, W., Bernasconi, P., Cheatham, L., Mansky, P., Popa-Burke, I., Williams, K., Worley, J., Hodge, N. (2004) Optimizing the Chemical Genomics Process. In: Darvas, F., Guttman, A., and Dorman, G. (eds.), Chemical Genomics. Marcel Dekker, New York, pp. 59–100.

    Google Scholar 

  11. Zhang, J.H., Chung, T.D., Oldenburg, K.R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67–73.

    CrossRef  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Blackwell, L.J. et al. (2009). High-Throughput Screening of the Cyclic AMP-Dependent Protein Kinase (PKA) Using the Caliper Microfluidic Platform. In: Janzen, W., Bernasconi, P. (eds) High Throughput Screening. Methods in Molecular Biology, vol 565. Humana Press. https://doi.org/10.1007/978-1-60327-258-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-258-2_11

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-257-5

  • Online ISBN: 978-1-60327-258-2

  • eBook Packages: Springer Protocols